Immunophenotyping of Acute Lymphoblastic Leukemia
Immunophenotyping by flow cytometry is an important component in the diagnostic evaluation of patients with acute lymphoblastic leukemia. This technique further permits the detection of minimal residual disease after therapy, a robust prognostic factor that may guide individualized treatment. We describe here laboratory methods for both the initial characterization of lymphoblasts at diagnosis, and the detection of rare leukemic lymphoblasts after treatment. In addition to antibody combinations suitable for diagnosis and detection of minimal residual disease, we describe procedures for peripheral blood and bone marrow sample preparation, procedures for labeling of cell-surface and intracellular proteins with fluorochrome-conjugated antibodies, and approaches to analysis of immunophenotypic data.
Key wordsImmunophenotyping Flow cytometry Acute lymphoblastic leukemia Minimal residual disease Antibodies
The authors gratefully acknowledge Dr. Brent Wood, University of Washington, Seattle, for his generous gift of WoodList 2.7.8 software.
- 1.Swerdlow SH, Campo E, Harris NL et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, LyonGoogle Scholar
- 2.Borowitz MJ, DiGiuseppe JA (2014) Acute lymphoblastic leukemia/lymphoblastic lymphoma. In: Orazi A, Weiss LM, Foucar K et al (eds) Knowles’ neoplastic hematopathology. Lippincott Williams & Wilkins, Philadelphia, pp 1019–1029Google Scholar
- 3.DiGiuseppe JA (2016) Acute lymphoblastic leukemia/lymphoma: diagnosis and minimal residual disease detection by flow cytometric immunophenotyping. In: Detrick B, Hamilton R, Schmitz J (eds) Manual of molecular and clinical laboratory immunology, 8th edn. ASM Press, Washington, D.C., pp 207–216Google Scholar
- 4.Wood B, Soma L (2016) Acute myeloid leukemia: diagnosis and minimal residual disease detection by flow cytometry. In: Detrick B, Schmitz J, Hamilton RG (eds) Manual of molecular and clinical laboratory immunology, 8th edn. ASM Press, Washington, D.C.Google Scholar
- 5.Borowitz MJ, Bene M-C, Harris NL et al (2017) Acute leukaemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 180–187Google Scholar
- 20.Shinoda-Matsuoka H, DiGiuseppe JA (2009) Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: efficiency of minimal residual disease (MRD) detection by flow cytometric immunophenotyping compared with commonly used markers. Mod Pathol 89:388AGoogle Scholar